1. Home
  2. Live Updates
  3. Archana sadhu

Live Breaking News & Updates on Archana sadhu

Stay informed with the latest breaking news from Archana sadhu on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Archana sadhu and stay connected to the pulse of your community

Semaglutide vs. tirzepatide: Comparing weight loss drugs like Ozempic

Semaglutide vs. tirzepatide: Comparing weight loss drugs like Ozempic
houstonchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from houstonchronicle.com Daily Mail and Mail on Sunday newspapers.

Eli-lilly , Deborah-horn , Drug-administration , Archana-sadhu , New-england-journal ,

Knowing your risks helps protect from the 'Modern Preventable Pandemic'

Knowing your risks helps protect from the ‘Modern Preventable Pandemic’

Saudi-arabia , International-diabetes-federation , Middle-east , Archana-sadhu , Houston-methodist , World-diabetes-day , Modern-preventable , Saudigazette-newspaper , Audi-sazette , Audigazette , Audi-arabia

Ozempic: What Happens When You Stop Taking It?

Ozempic isn’t a new drug, but the buzz around it is hard to ignore. That buzz is causing a shortage, which can have serious consequences for people with Type 2 diabetes.

Colorado , United-states , Ann-arbor , Michigan , Americans , Andy-cohen , Remi-bader , Andrew-kraftson , Daniel-bessesen , Atrium-health-wake-forest-baptist-medical-center , University-of-colorado-school-medicine , Obesity-medicine-association

Weight loss: U.S. FDA approves obesity drug

Regulators said a new version of a popular diabetes medicine could be sold as a weight-loss drug in the U.S.

Maryland , United-states , Denmark , Danish , Phylander-pannell , Novo-nordisk-victoza , Atherosclerosis-research-center , Drug-administration , Obesity-medicine-association , Novo-nordisk , Harold-bays , Louisville-metabolic

FDA approves first weight-loss drug since 2014

Wegovy helped certain people lose an average of 15% of their body weight.

United-states , American , John-sharretts , Drug-administration-on , Division-of-diabetes , Novo-nordisk , Drug-administration , Lipid-disorders , Drug-evaluation , Archana-sadhu , Houston-methodist-hospital , Food-and-drug-administration-fda

Houston doctor weighs in on new FDA approved obesity drug

A new version of a popular diabetes medicine could be sold as a weight-loss drug in the...

Maryland , United-states , Houston , Texas , Denmark , Danish , Lindaa-johnson , Phylander-pannell , Novo-nordisk-victoza , Science-department , Atherosclerosis-research-center , Obesity-medicine-association

U.S. FDA approves obesity drug that helped people cut weight 15%

The Food and Drug Administration approved Wegovy, a higher-dose version of Novo Nordisk's diabetes drug semaglutide, for long-term weight management.

Maryland , United-states , Denmark , Danish , Phylander-pannell , Novo-nordisk-victoza , Atherosclerosis-research-center , Drug-administration , Obesity-medicine-association , Novo-nordisk , Harold-bays , Louisville-metabolic

FDA approves diabetes medicine as weight-loss drug

The FDA has approved the diabetes medicine Wegovy to help people lose weight by 15%.

Maryland , United-states , Denmark , Danish , Phylander-pannell , Matthew-horwood-getty , Novo-nordisk-victoza , Atherosclerosis-research-center , Drug-administration , Obesity-medicine-association , Novo-nordisk , Wales-daily-life